Short answer
LENZ Therapeutics, Inc. (LENZ) filed an 8-K current report with the SEC on June 12, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). 24,442,068 of 31,354,394 outstanding shares represented at the June 12, 2026 annual meeting.
LENZ Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 24,442,068 of 31,354,394 outstanding shares represented at the June 12, 2026 annual meeting
- Evert Schimmelpennink, Jeff George, and Shelley Thunen elected as Class II directors through the 2029 annual meeting
- Jeff George faced materially higher opposition, with 6,984,497 votes withheld versus 13,462,359 votes for
- Ernst & Young LLP ratified as independent auditor for fiscal year ending December 31, 2026, with 24,310,915 votes for
- Auditor ratification passed with 55,181 votes against and 75,972 abstentions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LENZ Therapeutics, Inc. 8-K filings
Get the next LENZ 8-K as it lands
Follow LENZ for push alerts, or ask the research agent what this filing means.